Global Prostaglandin Market Overview
Prostaglandins are hormone-like compounds that are synthetized from arachidonic acid by cells in human body to act as chemical messengers. Prostaglandins are responsible for a variety of physiological effects, including the activation of the inflammatory response and the symptoms of pain and fever. It is found in animal and human tissue which can be derived enzymatically from fatty acids. When the human or animal body is bleeding, prostaglandins stimulates the formation of blood clot and contraction of blood vessels. Once, the blood clots are not needed and injury started to heal, another prostaglandins allow the clot to dissipate and blood vessels wall to relax.
The prostaglandins are formed by chemical reaction occurred on the part of the body which requires healing and can be made in all the organ of body. Generally, it is formed at the site of tissue damage or infection. The main application of prostaglandins is to initiate labor in pregnancy. It helps to contract the muscles of uterine walls and the suppositories of prostaglandin are inserted into vagina at the evening to go into labor by morning. The advantage of this method is, the patient can move freely in the labor room. Production of high level of prostaglandins can cause unwanted inflammation and leads to several diseases such as nausea, etc. Apart from the use of prostaglandins used in reproductive area, it is widely distributed in human body to produce different pharmacological effects such as regulation of blood pressure, treatment of hypertension and peripheral vascular disease. Additionally, the clinical application of prostaglandin is for induction of labor and reduction in early pregnancies.
Market Size & Forecast
The global prostaglandin market is anticipated to record a CAGR of around 4.8% over the forecast period i.e. 2019-2027. The market is segmented on the basis of end-user into cardiovascular, digestive and gynecological, ophthalmology and others, out of which, cardiovascular segment accounts for leading market share on the back of increasing number of geriatric population across the globe. Additionally, the application of human prostaglandin in females during pregnancies is projected to the market growth over the forecast period. Also, the role of prostaglandins in pathophysiology and treatment of various vascular disorder is further expected to boost the market in near future. CLICK TO DOWNLOAD FREE SAMPLE
Increase in Number of Migraine Headache Patients
The reason for implicating prostaglandins in the pathogenesis is migraine headaches as it has ability to produce constriction or relaxation of cerebral blood vessels. Prostaglandins may also be implicated as it reportedly potentiate the effects of bradykinin and other forms of chemically induced pain by sensitizing the peripheral pain receptors. Moreover, it helps in diagnosis of inflammatory disease such as edema, erythema and tissue damage and are capable of modulating the release of neuro - transmitters from nerve terminals. Prostaglandin inhibitors are effectively used for shortening the duration of migraine attacks and reduce the side effects such as nausea, vomiting and abdominal pain. These factors are projected to fuel the market growth over the forecast period.
Increase in Number of Cardiovascular Patients
Development in the area of neonatal cardiac surgery has increased the importance of rapid diagnosis and stabilization of infants with congenital heart disease. According to WHO report, every year 17.9 million dies due to cardiovascular disease which is 31% of total death in one year. With the increasing application of prostaglandin in early stage helps the patients to be more clinically stable for surgery and has also increase the probability of survival after cardiac defect repair. Therapy with prostaglandin can effectively maintain an infant's cardiovascular function until palliative or corrective procedure can be performed. Additionally, the growing geriatric population with major congenital heart disease is further projected to enhance the market growth over the forecast period.
The main problem with uneven prostaglandins is unwanted inflammation in body. Excessive production of prostaglandin can cause chronic disease with pain. Menstruation bleeding, arthritis and some type of cancer are connected to high amount of prostaglandin formation. Sometime, the formation of prostaglandin is not enough to heal the injury. This in turn is anticipated to hamper the market growth over the forecast period.
Our-in depth analysis of the global prostaglandin market includes the following segments:
On the basis of regional analysis, the global prostaglandin market is segmented into five regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The market in North America region is expected to display a significant growth owing to increasing number of congenital heart diseases in geriatric population. Further, the Europe market is anticipated to induce a steady growth on the back of increasing number of various vascular disease.
The market in Asia Pacific is estimated to highest growth during the forecast period on account of increasing application of prostaglandin in female during pregnancy to relief the labor pain.
The global prostaglandin market is further classified on the basis of region as follows:
Top Featured Companies Dominating the Market
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization